Literature DB >> 7017733

Coupling of protein antigens to erythrocytes through disulfide bond formation: preparation of stable and sensitive target cells for immune hemolysis.

Y H Jou, R B Bankert.   

Abstract

An efficient technique has been developed for coupling protein antigens to erythrocyte membranes. The procedure involves three steps. First, 3-(2-pyridyldithio)propionyl residues are introduced into the protein by reaction with a heterobifunctional reagent, N-succinimidyl 3-(pyridyldithio) propionate. Second, the addition of disulfide groups to sheep erythrocytes (SRBC) is achieved by coupling dithiodiglycolic acid to SRBC with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide. The disulfide bonds of the dithiodiglycolyl-SRBC conjugate are then reduced with dithiothreitol. Finally, the 3-(2-pyridyldithio)propionyl-protein conjugate is covalently coupled to the thiolated SRBC through thiol/disulfide exchange to form the disulfide-linked antigen-SRBC conjugate. The procedure requires only 10-500 microgram of protein antigen for the preparation of 50 microliter of packed protein-coupled SRBC. Antibodies binding to antigen on the erythrocyte initiate a complement-dependent immune lysis of the target cells. Target cells prepared by this method are stable for at least 4 wk at 4 degrees C in phosphate buffer (pH 7.2) and are capable of detecting as little as 40 pg of antibody in a hemolytic assay without noticeable nonspecific lysis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7017733      PMCID: PMC319373          DOI: 10.1073/pnas.78.4.2493

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  The coupling of protein antigens to erythrocytes with difluorodinitrobenzene.

Authors:  N R LING
Journal:  Immunology       Date:  1961-01       Impact factor: 7.397

2.  Synthesis of a lipopolysaccharide designed to conjugate haptens and proteins to erythrocyte for use as target cells in passive hemagglutination and hemolytic assays.

Authors:  R B Bankert; G L Mayers; D Pressman
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

Review 3.  Plaque forming cells: methodology and theory.

Authors:  N K Jerne; C Henry; A A Nordin; H Fuji; A M Koros; I Lefkovits
Journal:  Transplant Rev       Date:  1974

4.  The use of a wate-soluble carbodiimide as a coupling reagent in the passive hemagglutination test.

Authors:  H M Johnson; K Brenner; H E Hall
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

5.  A modification of the hemolytic plaque assay for use with protein antigens.

Authors:  E S Golub; R I Mishell; W O Weigle; R W Dutton
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

6.  The hyaline layer: its isolation and role in echinoderm development.

Authors:  E Citkowitz
Journal:  Dev Biol       Date:  1971-03       Impact factor: 3.582

7.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

8.  Immunochemistry of monoclonal antibodies.

Authors:  G L Mayers; R B Bankert
Journal:  Transplant Proc       Date:  1980-09       Impact factor: 1.066

9.  Screening and replica plating of anti-hapten hybridomas with a transfer template hemolytic spot assay.

Authors:  R B Bankert; D DesSoye; L Powers
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

10.  The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera.

Authors:  S V BOYDEN
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

View more
  2 in total

1.  Steric effects in peptide and protein exchange with activated disulfides.

Authors:  Jason Kerr; Jessica L Schlosser; Donald R Griffin; Darice Y Wong; Andrea M Kasko
Journal:  Biomacromolecules       Date:  2013-07-19       Impact factor: 6.988

2.  IgE class-restricted tolerance induced by neonatal administration of soluble or cell-bound IgE.

Authors:  S S Chen; D H Katz
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.